Company intelligence / Profile preview

Cobe Cardiovascular

Ownership: Private
Development stage: Other

Overview

Cobe Cardiovascular was a leading medical technology company specializing in products for extracorporeal circulation and cardiac surgery. The company was widely recognized for its heart-lung machines, blood oxygenators, and autotransfusion systems used globally in operating rooms. Originally a division of COBE Laboratories, it established a significant market presence before being acquired by the Sorin Group in 1999. Its technological legacy remains a core component of the cardiopulmonary portfolio of LivaNova, the successor entity following the merger of Sorin and Cyberonics.

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Cobe Cardiovascular.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cobe Cardiovascular.